Spencer Z. Rosero
Chief Tech/Sci/R&D Officer at Efferent Labs, Inc.
Profile
Spencer Z.
Rosero is the founder of Physiologic Communications LLC, founded in 2004.
He is currently the Director & Chief Medical Officer at Efferent Labs, Inc. and a Professor at the University of Rochester.
Spencer Z. Rosero active positions
Companies | Position | Start |
---|---|---|
Rochester Christian University | Corporate Officer/Principal | - |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Efferent Labs, Inc. operates as a preclinical stage biotechnology company. The firm focuses on implantable biosensors for life sciences. Its CytoComm biosensor platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases. The company was founded by William K. Rader and is headquartered in Buffalo, NY. | Chief Tech/Sci/R&D Officer | - |
Former positions of Spencer Z. Rosero
Companies | Position | End |
---|---|---|
Physiologic Communications LLC
Physiologic Communications LLC Medical SpecialtiesHealth Technology Physiologic Communications LLC designs and develops implantable electronic devices. It offers implantable wireless biosensors that integrate living cells and a tool to monitor biochemical signals. The company was founded by Spencer Z. Rosero on July 12, 2004 and is headquartered in Rochester, NY | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Physiologic Communications LLC
Physiologic Communications LLC Medical SpecialtiesHealth Technology Physiologic Communications LLC designs and develops implantable electronic devices. It offers implantable wireless biosensors that integrate living cells and a tool to monitor biochemical signals. The company was founded by Spencer Z. Rosero on July 12, 2004 and is headquartered in Rochester, NY | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Efferent Labs, Inc. operates as a preclinical stage biotechnology company. The firm focuses on implantable biosensors for life sciences. Its CytoComm biosensor platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases. The company was founded by William K. Rader and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- Spencer Z. Rosero